DUBLIN--(BUSINESS WIRE)--The "The Corporate Reputation of Pharma in 2019 - The Patient Perspective - Global Edition - The Views of 1,850 Patient Groups" report has been added to ResearchAndMarkets.com ...

ST GALLEN, Switzerland--(BUSINESS WIRE)--Regulatory News: Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while ...

Every year, new drugs are approved and older ones go generic. Physicians prescribe medicines and patients take them (usually). Payers extend coverage for brands and exclude others from formularies. Of ...

Headwinds ranging from an expected renewal of political wrangling over the price of prescription drugs to increasing pressure on sales of established treatments have largely, but not entirely, kept ...

While TV watchers saw more pharma brand in commercials in 2019, overall total category spending was flat. (3dman_eu) () Pharma TV spending held steady in 2019, finishing the year with a total for the ...

Ladies and gentlemen, thank you for standing by and welcome to the China Pharma Holdings Incorporated FY 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. There ...

"We entered 2020 with a focused agenda for leveraging our Accordion Pill platform in both the near- and long-term, with goals to outlicence our late-stage Parkinson's disease program, to advance our ...

Direct-to-consumer drug ads tend to strike a dissonant chord. However, fan and foe can count on one thing: Prescription DTC advertising is here to stay. The evidence? Surviving more than 20 years of ...

According to information procured exclusively ahead of a formal announcement Friday, a subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to ...

In 2019, total revenue declined 8% to $16.9 billion, but rising sales of some newer drugs more than offset the falling sales of Copaxone during the last three months of the year. Fourth-quarter sales ...

BridgeBio Pharma (NASDAQ: BBIO) is a U.S.-based early stage bio-pharmaceutical development company relying on gene sequencing. The company listed on NASDAQ in June 2019 at a price of $17 and has seen ...

Purdue Pharma has filed for bankruptcy as part of its plan to settle litigation with dozens of states and and other plaintiffs who say the company fueled the opioid crisis. Now the billionaire family ...